I agree, unless I'm mistaken it doesn't help us with the dermatitis trial since it's already underway so the batches of product would have already been produced. Looking longer term it might bode well for future trials, we might be able to import from the Australian acne trial manufacturer into the US now?
What I think Botanix has failed to mention is is who is the supplier of the Aussie produced CBD from the acne trials, was it Purisys? If not it just creates more uncertainty for the results of the upcoming dermatitis trial.The US active performance was on par with the Aus active wasn't it? It was just that the US vehicle only performance was on par the US active.
The US active performance was on par with the Aus active wasn't...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.0¢ | $1.108M | 3.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 382148 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 346312 | 5 |
View Market Depth
| Last trade - 10.45am 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
-0.010 ( 0.90 %) |
||||
| Open | High | Low | Volume | ||
| 29.3¢ | 29.5¢ | 28.0¢ | 827606 | ||
| Last updated 11.04am 09/05/2024 ? | |||||
| BOT (ASX) Chart |